Page last updated: 2024-08-22

nifuratel and Stomach Neoplasms

nifuratel has been researched along with Stomach Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cai, A; Chen, R; Chen, Z; Jiang, X; Kou, L; Lin, X; Wang, J; Yao, Q; Zheng, H; Zhou, B	1

Other Studies

1 other study(ies) available for nifuratel and Stomach Neoplasms

Article	Year
Nanoparticle mediated codelivery of nifuratel and doxorubicin for synergistic anticancer therapy through STAT3 inhibition. Colloids and surfaces. B, Biointerfaces, 2020, Volume: 193 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Mitochondria; Nanoparticles; Nifuratel; Particle Size; Phosphorylation; Polylactic Acid-Polyglycolic Acid Copolymer; STAT3 Transcription Factor; Stomach Neoplasms; Surface Properties; Wound Healing	2020

Article

Year

Nanoparticle mediated codelivery of nifuratel and doxorubicin for synergistic anticancer therapy through STAT3 inhibition.

Colloids and surfaces. B, Biointerfaces, 2020, Volume: 193

Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Mitochondria; Nanoparticles; Nifuratel; Particle Size; Phosphorylation; Polylactic Acid-Polyglycolic Acid Copolymer; STAT3 Transcription Factor; Stomach Neoplasms; Surface Properties; Wound Healing

2020